Regional banks such as First Horizon (FHN) and F.N.B. (FNB) navigate competitive landscapes in the Southeastern and Mid-Atlantic markets, delivering commercial, consumer banking, and wealth management services. Their earnings reports offer a clear window into net interest margin (NIM, the spread between interest income and funding costs), loan growth, deposit stability, and credit quality as interest rates shift and the economy evolves. From my perspective, FHN, based in Memphis, Tennessee, stands out for its focus on mortgage company lending, while Pittsburgh-headquartered FNB emphasizes diversified fee income and digital advancements. Comparing their Q1 2026 outcomes sheds light on operational efficiencies, risk management, and growth prospects in this normalizing rate environment.
First Horizon (FHN) is set to release Q1 2026 earnings on April 15 before the market opens, with a conference call at 9:30 AM ET. Analysts expect EPS of $0.49, up from $0.42 a year ago, alongside revenue of about $869 million, pointing to 6-7% top-line growth. In my view, key supports here include a steady NIM around 3.5%, bolstered by falling deposit costs and lending to mortgage companies. Last quarter, in Q4 2025, FHN posted EPS of $0.52, topping the $0.46 consensus, NII of $676 million (up 7% year-over-year), and ROTCE of 15%. With $84 billion in assets, $67 billion in deposits, and CET1 near 11%, the balance sheet looks solid. One thing I'm watching closely is loan growth and credit provisions, given the commercial real estate exposure.
I also checked this using Tickeron’s AI Screener to gauge how FHN stacks up against peers on these metrics.
F.N.B. (FNB) will report Q1 2026 results after market close on April 16, followed by a call on April 17 at 8:30 AM ET. The consensus points to EPS of $0.38 on $454 million in revenue. In Q4 2025, FNB achieved operating EPS of $0.50 (beating $0.41 estimates), record NII of $365 million (up 13% year-over-year), and NIM of 3.3%. Assets reached $50 billion, deposits $38 billion (loan-to-deposit ratio at 89%), CET1 around 11%, and ROTCE at 16%. Fee-based revenue from wealth management and service charges grew strongly, aided by technology investments and market share expansion. Recent auto loan sales have helped optimize yields, setting the stage for further progress. The upcoming numbers will reveal more on deposit stability and expense discipline.
FHN holds an edge in scale, with $84 billion in assets compared to FNB's $50 billion, and a $11.6 billion market cap versus $6.3 billion, alongside a slightly higher NIM (3.5% vs. 3.3%). This translates to greater absolute earnings power—TTM EPS of $1.89 for FHN against FNB's $1.56. Both exceeded Q4 estimates, though FNB demonstrated a ROTCE advantage (16% vs. 15%) and better deposit beta control. Growth comes from FHN's specialty lending on one side and FNB's diversified non-interest income (up 9% linked-quarter) on the other. Risks involve FHN's mortgage sensitivity and their mutual commercial real estate exposure, but provisions stay conservative, with low net charge-offs. Analyst sentiment remains constructive: FHN at a $26 target (Hold/Buy mix), FNB at $20 (Buy). From what I see, FNB's lower volatility suits stability seekers, while FHN presents upside through asset repricing.
In my own research and trading routine, I rely on Tickeron’s AI Screener, an AI-powered tool for discovering stocks and ETFs. It lets me filter thousands of names using technical patterns, fundamentals, trends, volatility, and AI signals—customizing by industry, market cap, indicators, price patterns, and performance metrics. This approach uncovers trade ideas, trending stocks, breakouts, and opportunities far more efficiently than manual scans. It's become a key part of how I streamline my process, and I recommend exploring it to sharpen your own analysis.
Tickeron AI currently favors FHN (60% probability) for superior earnings quality, larger scale, and NIM expansion potential, though FNB's stability and ROTCE edge make it a close contender in risk-adjusted positioning.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
The 10-day moving average for FHN crossed bullishly above the 50-day moving average on April 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
FHN moved above its 50-day moving average on April 08, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FHN advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .
FHN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 304 cases where FHN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for FHN moved out of overbought territory on April 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator moved out of overbought territory. In of the 45 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on May 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FHN as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for FHN turned negative on May 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FHN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.354) is normal, around the industry mean (1.173). P/E Ratio (12.080) is within average values for comparable stocks, (17.190). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.335). Dividend Yield (0.026) settles around the average of (0.035) among similar stocks. P/S Ratio (3.580) is also within normal values, averaging (3.576).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. FHN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock slightly worse than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a regional bank
Industry RegionalBanks